Log in
Enquire now
‌

US Patent 8148076 Gene expression profiling of EGFR positive cancer

Patent 8148076 was granted and assigned to Genomic Health on April, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Genomic Health
Genomic Health
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8148076
Patent Inventor Names
Maureen T. Cronin0
Joffre B. Baker0
Jose Baselga0
Steven Shak0
Date of Patent
April 3, 2012
Patent Application Number
13150799
Date Filed
June 1, 2011
Patent Citations Received
‌
US Patent 11776661 Determination of MAPK-AP-1 pathway activity using unique combination of target genes
‌
US Patent 12125561 Determination of JAK-STAT3 pathway activity using unique combination of target genes
0
‌
US Patent 11649488 Determination of JAK-STAT1/2 pathway activity using unique combination of target genes
0
Patent Primary Examiner
‌
Amanda Shaw
Patent abstract

The present invention concerns prognostic markers associated with EGFR positive cancer. In particular, the invention concerns prognostic methods based on the molecular characterization of gene expression in paraffin-embedded, fixed tissue samples of EGFR-expressing cancer, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8148076 Gene expression profiling of EGFR positive cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us